5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)-

5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)- Basic information
Product Name:5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)-
Synonyms:5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)-;PRMT5-IN-11
CAS:2567564-33-2
MF:C13H17N5O4
MW:307.31
EINECS:
Product Categories:
Mol File:2567564-33-2.mol
5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)- Structure
5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)- Chemical Properties
Boiling point 691.8±65.0 °C(Predicted)
density 2.00±0.1 g/cm3(Predicted)
pka13.10±0.70(Predicted)
Safety Information
MSDS Information
5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)- Usage And Synthesis
UsesPRMT5-IN-11 is a promising structure-dependent inhibition of the protein methyltransferase PRMT5:MEP50 complex in the (sub)micromolar range.
References[1] Jouffroy L, et al. Regio- and Stereoselective Synthesis of C-4' Spirocyclobutyl Ribofuranose Scaffolds and Their Use as Biologically Active Nucleoside Analogues. Org Lett. 2021 Nov 19;23(22):8828-8833. DOI:10.1021/acs.orglett.1c03334
5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)- Preparation Products And Raw materials
Tag:5-Oxaspiro[3.4]octane-7,8-diol, 6-(6-amino-9H-purin-9-yl)-1-(hydroxymethyl)-, (1R,4R,6R,7R,8S)-(2567564-33-2) Related Product Information
UNC0638 DS-3201 SGC0946 Chaetocin MS1943 N-(6-amino-5-ethylpyridin-3-yl)-2-((2R,5S)-5-methyl-2-(2-(1-methylpiperidin-4-yl)benzo[d]thiazol-5-yl)piperidin-1-yl)-2-oxoacetamide